A Comparison between Endostatin and Conventional Biomarkers on 30-Day Mortality and Renal Replacement Therapy in Unselected Intensive Care Patients

Endostatin may predict mortality and kidney impairment in general populations as well as in critically ill patients. We decided to explore the possible role of endostatin as a predictor of 30-day mortality, acute kidney injury (AKI), and renal replacement therapy (RRT) in a cohort of unselected inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruge, Toralph, Larsson, Anders, Lipcsey, Miklós, Tydén, Jonas, Johansson, Joakim, Eriksson, Mats
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615500/
https://www.ncbi.nlm.nih.gov/pubmed/34829832
http://dx.doi.org/10.3390/biomedicines9111603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615500/
https://www.ncbi.nlm.nih.gov/pubmed/34829832
http://dx.doi.org/10.3390/biomedicines9111603

Ejemplares similares